Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$948K Sell
7,327
-9,075
-55% -$1.06M 0.01% 206
2026
Q1
$1.99M Buy
16,402
+6,365
+63% +$735K 0.03% 156
2025
Q4
$1.07M Buy
+10,037
New +$942K 0.02% 197
2025
Q3
Sell
-11,782
Closed -$942K 395
2025
Q2
$942K Sell
11,782
-318,010
-96% -$25.3M 0.02% 191
2025
Q1
$29.9M Sell
329,792
-66
-0% -$6.16K 0.59% 38
2024
Q4
$33.1M Sell
329,858
-139,644
-30% -$14.4M 0.63% 36
2024
Q3
$53.7M Sell
469,502
-5,174
-1% -$615K 1.08% 17
2024
Q2
$59.1M Sell
474,676
-1,545
-0.3% -$199K 1.23% 17
2024
Q1
$63.2M Sell
476,221
-7,642
-2% -$942K 1.4% 14
2023
Q4
$53.1M Buy
+483,863
New +$50.2M 1.37% 13

Other funds holding MRK

Sapient Capital's MRK Position: Q2 2026 in Review

Sapient Capital reduced its Merck (MRK) stake by 55% in Q2 2026, selling an estimated $1.06M and leaving 7,327 shares worth $948K. The position accounts for 0.01% of the portfolio, ranked #206.

Sapient Capital first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $63.2M in Q1 2024. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sapient Capital held 7,327 shares of Merck worth $948K as of Q2 2026.
  • Sapient Capital sold 9,075 Merck shares in Q2 2026, an estimated $1.06M.
  • Merck made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #206 holding.
  • Sapient Capital first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Sapient Capital's Merck position peaked at $63.2M in Q1 2024.
  • 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.